Paraneoplastic acanthosis nigricans paralleling disease course in a patient with mycosis fungoides

Yann Charli‐Joseph(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Laura B. Pincus(University of California, San Francisco), Philip E. LeBoit(University of California, San Francisco), Weiyun Z. Ai(City College of San Francisco), Chong Ae Kim(AstraZeneca (United States))

European Journal of Dermatology

November 1, 2013

10.1684/ejd.2013.2232

Cited by 5

Related Papers

LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development

|Cell|2001|2.2k

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

|Blood|2013|683

In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study

|Journal of Clinical Oncology|2010|487

Fluorescence In Situ Hybridization (FISH) as an Ancillary Diagnostic Tool in the Diagnosis of Melanoma

|The American Journal of Surgical Pathology|2009|470

Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial

|The Lancet Oncology|2021|428